240 related articles for article (PubMed ID: 10467404)
1. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo.
Majello B; Napolitano G; Giordano A; Lania L
Oncogene; 1999 Aug; 18(32):4598-605. PubMed ID: 10467404
[TBL] [Abstract][Full Text] [Related]
2. Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation.
Ivanov D; Kwak YT; Nee E; Guo J; García-Martínez LF; Gaynor RB
J Mol Biol; 1999 Apr; 288(1):41-56. PubMed ID: 10329125
[TBL] [Abstract][Full Text] [Related]
3. Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression.
Romano G; Kasten M; De Falco G; Micheli P; Khalili K; Giordano A
J Cell Biochem; 1999 Dec; 75(3):357-68. PubMed ID: 10536359
[TBL] [Abstract][Full Text] [Related]
4. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
[TBL] [Abstract][Full Text] [Related]
5. Tackling Tat.
Karn J
J Mol Biol; 1999 Oct; 293(2):235-54. PubMed ID: 10550206
[TBL] [Abstract][Full Text] [Related]
6. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo.
Veschambre P; Simard P; Jalinot P
J Mol Biol; 1995 Jul; 250(2):169-80. PubMed ID: 7608968
[TBL] [Abstract][Full Text] [Related]
7. Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure.
Sano M; Wang SC; Shirai M; Scaglia F; Xie M; Sakai S; Tanaka T; Kulkarni PA; Barger PM; Youker KA; Taffet GE; Hamamori Y; Michael LH; Craigen WJ; Schneider MD
EMBO J; 2004 Sep; 23(17):3559-69. PubMed ID: 15297879
[TBL] [Abstract][Full Text] [Related]
8. Implication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 gene.
Giraud S; Hurlstone A; Avril S; Coqueret O
Oncogene; 2004 Sep; 23(44):7391-8. PubMed ID: 15286705
[TBL] [Abstract][Full Text] [Related]
9. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
Fujinaga K; Irwin D; Geyer M; Peterlin BM
J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330
[TBL] [Abstract][Full Text] [Related]
10. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
Seipel K; Georgiev O; Gerber HP; Schaffner W
Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of cyclin T1/CDK9 complexes during T cell activation.
Garriga J; Peng J; Parreño M; Price DH; Henderson EE; Graña X
Oncogene; 1998 Dec; 17(24):3093-102. PubMed ID: 9872325
[TBL] [Abstract][Full Text] [Related]
12. Catalytic activity of Cdk9 is required for nuclear co-localization of the Cdk9/cyclin T1 (P-TEFb) complex.
Napolitano G; Majello B; Lania L
J Cell Physiol; 2003 Oct; 197(1):1-7. PubMed ID: 12942536
[TBL] [Abstract][Full Text] [Related]
13. Cellular control of gene expression by T-type cyclin/CDK9 complexes.
Garriga J; Graña X
Gene; 2004 Aug; 337():15-23. PubMed ID: 15276198
[TBL] [Abstract][Full Text] [Related]
14. Functional inactivation of Cdk9 through oligomerization chain reaction.
Napolitano G; Mazzocco A; Fraldi A; Majello B; Lania L
Oncogene; 2003 Jul; 22(31):4882-8. PubMed ID: 12894230
[TBL] [Abstract][Full Text] [Related]
15. Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation.
De Falco G; Bagella L; Claudio PP; De Luca A; Fu Y; Calabretta B; Sala A; Giordano A
Oncogene; 2000 Jan; 19(3):373-9. PubMed ID: 10656684
[TBL] [Abstract][Full Text] [Related]
16. Cyclin-dependent kinase-9: an RNAPII kinase at the nexus of cardiac growth and death cascades.
Sano M; Schneider MD
Circ Res; 2004 Oct; 95(9):867-76. PubMed ID: 15514168
[TBL] [Abstract][Full Text] [Related]
17. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.
O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q
J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616
[TBL] [Abstract][Full Text] [Related]
18. Recruitment of TBP or TFIIB to a promoter proximal position leads to stimulation of RNA polymerase II transcription without activator proteins both in vivo and in vitro.
Huh JR; Park JM; Kim M; Carlson BA; Hatfield DL; Lee BJ
Biochem Biophys Res Commun; 1999 Mar; 256(1):45-51. PubMed ID: 10066420
[TBL] [Abstract][Full Text] [Related]
19. CDK9 has the intrinsic property to shuttle between nucleus and cytoplasm, and enhanced expression of cyclin T1 promotes its nuclear localization.
Napolitano G; Licciardo P; Carbone R; Majello B; Lania L
J Cell Physiol; 2002 Aug; 192(2):209-15. PubMed ID: 12115727
[TBL] [Abstract][Full Text] [Related]
20. Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome.
Kiernan RE; Emiliani S; Nakayama K; Castro A; Labbé JC; Lorca T; Nakayama Ki K; Benkirane M
Mol Cell Biol; 2001 Dec; 21(23):7956-70. PubMed ID: 11689688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]